Published 1996 | Version v1
Journal article

Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia

  • 1. Department of Clinacal Hematology, University Hospital, Charles University, Faculty of Medicine, 500 05 Hradec Kralove (Czech Republic)
  • 2. Institute of Pathology, University Hospital, Chahrles University, Faculty of Medicine, Hradec Kralove (Czech Republic)
  • 3. Department of Medicine, Uniuversity Hospital, Charles University, Faculty of Medicine, Hradec Kralove (Czech Republic)
  • 4. Institute of Clinical Biochemistry and Diagnostics, University Hospital, Charles University, Faculty of Medicine, Hradec Kralove (Czech Republic)

Description

Hairy cell leukemia is a chronic lymphoproliferative disorder of B-cell lineage. Malignant cells express the interleukin-2 receptor (IL-2R) which is released in vitro as well as in vivo. The sera of patients with hairy cell leukemia contain elevated levels of this soluble receptor (sIL-2R). Sere of 24 patients with hairy cell leukemia were tested for sIL-2R. In 9 patients treated with 2-chloro-deoxyadenosine an improved clinical status was associated with decreasing serum sIL-2R. The maximal rate of decrease of sIL-2R level was observed within the second and the third week after the therapy initiation. Patients with disease progression had an increase in serum sIL-2R level. Our results suggest that serial can be used as a reliable, noninvasive means to assess the disease activity and its response to therapy. (author)

Additional details

Publishing Information

Journal Title
Neoplasma
Journal Volume
43
Journal Issue
5
Journal Page Range
p. 321-325
ISSN
0028-2685

Optional Information

Notes
2 figs., 4 tabs., 15 refs.